Dennis P. West

University of Utah — United States

Medicine · Health Sciences

53h-index9.7kcitations333works0.12yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug-Induced Adverse Reactions(25), Cutaneous Melanoma Detection and Management(24), Psoriasis: Treatment and Pathogenesis(22), Pharmacovigilance and Adverse Drug Reactions(22), Dermatology and Skin Diseases(21)

Publications333 total

60412 Safety and efficacy of topical zabalafin as a uniquely singular approach to comprehensive and effective AD management and with or without concurrent Staphylococcus aureus (SA) or MRSA infection

Journal of the American Academy of Dermatology·2025Open Access

64686 Racial and Gender Disparities in Patients with Hidradenitis Suppurativa Requiring Systemic Therapy

Journal of the American Academy of Dermatology·2025

The Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment Option

Journal of Drugs in Dermatology·2025

0288 Direct immunofluorescence for oral lichen planus

Journal of Investigative Dermatology·2025Open Access

Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection

Journal of Drugs in Dermatology·2025

Non-melanoma skin cancer and other adverse events resulting from antihypertensive drug use: what do we know?

Expert Opinion on Drug Safety·2025

Epidemiological analysis of mycosis fungoides (<scp>MF</scp>) in children and young adult patient populations: A population‐based analysis of the nationwide surveillance, epidemiology and end results (<scp>SEER</scp>) database

Journal of the European Academy of Dermatology and Venereology·2024Open Access

49227 Cause of Death for Mycosis Fungoides or Sezary Syndrome from 2000-2020: A US Population-Based Analysis of SEER Patient Data

Journal of the American Academy of Dermatology·2024

53950 Risk of thromboembolic events for JAK inhibitors in dermatology: pharmacovigilance analysis of real-world evidence in the Food and Drug Administration Adverse Event Reporting System (FAERS) from the RADAR (Research on Adverse Drug events And Reports) Prog

Journal of the American Academy of Dermatology·2024

Subcision with and without suction for acne scars: a split-faced, rater-blinded randomized control trial

1 cited

Archives of Dermatological Research·2024· 1 cited

Subcision with and without suction for acne scars: A split-faced, rater-blinded randomized control trial

Research Square (Research Square)·2024Open Access

Machine learning identification of patient clusters for cutaneous melanoma

Italian Journal of Dermatology and Venereology·2023

41036 A machine learning approach to identify phenotype-based clustering with apparent prognostic risk factors in patients with cutaneous melanoma

Journal of the American Academy of Dermatology·2023Open Access

40527 An epidemiological analysis of mycosis fungoides (MF) in children and young adult populations: a population-based study from the Surveillance, Epidemiology and End Results (SEER) database

Journal of the American Academy of Dermatology·2023Open Access

The climate sprint: an agile process for catalytic collaboration towards a just transition

1 cited

Edward Elgar Publishing eBooks·2023· 1 cited

Data from Histopathologic and Immunohistochemical Characterization of Rash to Human Epidermal Growth Factor Receptor 1 (HER1) and HER1/2 Inhibitors in Cancer Patients

2023Open Access

Supplementary Data from Histopathologic and Immunohistochemical Characterization of Rash to Human Epidermal Growth Factor Receptor 1 (HER1) and HER1/2 Inhibitors in Cancer Patients

2023Open Access

Data from Histopathologic and Immunohistochemical Characterization of Rash to Human Epidermal Growth Factor Receptor 1 (HER1) and HER1/2 Inhibitors in Cancer Patients

2023Open Access

Supplementary Data from Histopathologic and Immunohistochemical Characterization of Rash to Human Epidermal Growth Factor Receptor 1 (HER1) and HER1/2 Inhibitors in Cancer Patients

2023Open Access

A novel broad-spectrum (anti-inflammatory, anti-pruritic and anti-S. aureus/MRSA) topical drug compound for mild to moderate atopic dermatitis

Journal of Allergy and Clinical Immunology·2023Open Access

page 1 of 17Next →

Frequent Co-authors

Beatrice Nardone(10), Dennis W. Raisch(8), Steven M. Belknap(7), Mario E. Lacouture(7), Murad Alam(7), June M. McKoy(6), Emily Poon(6), Simon Yoo(6), Alfred Rademaker(6), Beatrice J. Edwards(6), Charles L. Bennett(5), Michael Nodzenski(4), Emir Veledar(4), Giuseppe Micali(4), Paul R. Yarnold(3), Natalie Pace(3), Anne E. Laumann(3), Steven Trifilio(3), Tina Kiguradze(3), Jonathan R. Nebeker(2)